FHIR IG analytics| Package | hl7.fhir.uv.xver-r2.r4b |
| Resource Type | ValueSet |
| Id | ValueSet-R2-v2-0227-for-R4B.json |
| FHIR Version | R4B |
| Source | http://hl7.org/fhir/uv/xver-r2.r4b/0.1.0/ValueSet-R2-v2-0227-for-R4B.html |
| URL | http://hl7.org/fhir/uv/xver/ValueSet/R2-v2-0227-for-R4B |
| Version | 0.1.0 |
| Status | active |
| Date | 2026-03-17T21:02:03.8104715+00:00 |
| Name | R2V20227ForR4B |
| Title | Cross-version ValueSet DSTU2.v2 Manufacturers of Vaccines (code=MVX) for use in FHIR R4B |
| Realm | uv |
| Authority | hl7 |
| Description | This cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/v2-0227|2.8.2` for use in FHIR R4B. |
| Purpose | This value set is part of the cross-version definitions generated to enable use of the value set `http://hl7.org/fhir/ValueSet/v2-0227|2.8.2` as defined in FHIR DSTU2 in FHIR R4B. The source value set is bound to the following FHIR DSTU2 elements: * Across FHIR versions, the value set has been mapped as: * `http://hl7.org/fhir/ValueSet/v2-0227|2.8.2` * `http://hl7.org/fhir/ValueSet/v2-0227|2.8.2` * `http://terminology.hl7.org/ValueSet/v2-0227|2.9` Note that all concepts are included in this cross-version definition because no concepts have compatible representations Following are the generation technical comments: All concepts in the comparison are listed as identical. The source and target value sets have the same number of active concepts (55). All concepts in the comparison are listed as identical. The source and target value sets have the same number of active concepts (55). FHIR ValueSet `http://hl7.org/fhir/ValueSet/v2-0227|2.8.2`, defined in FHIR DSTU2 does not have any mapping to FHIR R4B |
No resources found
| CodeSystem | ||
| hl7.fhir.uv.xver-r2.r4b#0.1.0 | 0227 | v2-0227 |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet R2-v2-0227-for-R4B
This value set expansion contains 55 concepts.
| System | Version | Code | Display |
http://hl7.org/fhir/v2/0227 | 1.0.2 | AB | Abbott Laboratories |
http://hl7.org/fhir/v2/0227 | 1.0.2 | AD | Adams Laboratories, Inc. |
http://hl7.org/fhir/v2/0227 | 1.0.2 | ALP | Alpha Therapeutic Corporation |
http://hl7.org/fhir/v2/0227 | 1.0.2 | AR | Armour |
http://hl7.org/fhir/v2/0227 | 1.0.2 | AVB | Aventis Behring L.L.C. |
http://hl7.org/fhir/v2/0227 | 1.0.2 | AVI | Aviron |
http://hl7.org/fhir/v2/0227 | 1.0.2 | BA | Baxter Healthcare Corporation |
http://hl7.org/fhir/v2/0227 | 1.0.2 | BAH | Baxter Healthcare Corporation |
http://hl7.org/fhir/v2/0227 | 1.0.2 | BAY | Bayer Corporation |
http://hl7.org/fhir/v2/0227 | 1.0.2 | BP | Berna Products |
http://hl7.org/fhir/v2/0227 | 1.0.2 | BPC | Berna Products Corporation |
http://hl7.org/fhir/v2/0227 | 1.0.2 | CEN | Centeon L.L.C. |
http://hl7.org/fhir/v2/0227 | 1.0.2 | CHI | Chiron Corporation |
http://hl7.org/fhir/v2/0227 | 1.0.2 | CMP | Celltech Medeva Pharmaceuticals |
http://hl7.org/fhir/v2/0227 | 1.0.2 | CNJ | Cangene Corporation |
http://hl7.org/fhir/v2/0227 | 1.0.2 | CON | Connaught |
http://hl7.org/fhir/v2/0227 | 1.0.2 | DVC | DynPort Vaccine Company, LLC |
http://hl7.org/fhir/v2/0227 | 1.0.2 | EVN | Evans Medical Limited |
http://hl7.org/fhir/v2/0227 | 1.0.2 | GEO | GeoVax Labs, Inc. |
http://hl7.org/fhir/v2/0227 | 1.0.2 | GRE | Greer Laboratories, Inc. |
http://hl7.org/fhir/v2/0227 | 1.0.2 | IAG | Immuno International AG |
http://hl7.org/fhir/v2/0227 | 1.0.2 | IM | Merieux |
http://hl7.org/fhir/v2/0227 | 1.0.2 | IUS | Immuno-U.S., Inc. |
http://hl7.org/fhir/v2/0227 | 1.0.2 | JPN | The Research Foundation for Microbial Diseases of Osaka University |
http://hl7.org/fhir/v2/0227 | 1.0.2 | KGC | Korea Green Cross Corporation |
http://hl7.org/fhir/v2/0227 | 1.0.2 | LED | Lederle |
http://hl7.org/fhir/v2/0227 | 1.0.2 | MA | Massachusetts Public Health Biologic Laboratories |
http://hl7.org/fhir/v2/0227 | 1.0.2 | MBL | Massachusetts Biologic Laboratories |
http://hl7.org/fhir/v2/0227 | 1.0.2 | MED | MedImmune, Inc. |
http://hl7.org/fhir/v2/0227 | 1.0.2 | MIL | Miles |
http://hl7.org/fhir/v2/0227 | 1.0.2 | MIP | Bioport Corporation |
http://hl7.org/fhir/v2/0227 | 1.0.2 | MSD | Merck & Co., Inc. |
http://hl7.org/fhir/v2/0227 | 1.0.2 | NAB | NABI |
http://hl7.org/fhir/v2/0227 | 1.0.2 | NAV | North American Vaccine, Inc. |
http://hl7.org/fhir/v2/0227 | 1.0.2 | NOV | Novartis Pharmaceutical Corporation |
http://hl7.org/fhir/v2/0227 | 1.0.2 | NVX | Novavax, Inc. |
http://hl7.org/fhir/v2/0227 | 1.0.2 | NYB | New York Blood Center |
http://hl7.org/fhir/v2/0227 | 1.0.2 | ORT | Ortho-Clinical Diagnostics |
http://hl7.org/fhir/v2/0227 | 1.0.2 | OTC | Organon Teknika Corporation |
http://hl7.org/fhir/v2/0227 | 1.0.2 | OTH | Other manufacturer |
http://hl7.org/fhir/v2/0227 | 1.0.2 | PD | Parkedale Pharmaceuticals |
http://hl7.org/fhir/v2/0227 | 1.0.2 | PMC | sanofi pasteur |
http://hl7.org/fhir/v2/0227 | 1.0.2 | PRX | Praxis Biologics |
http://hl7.org/fhir/v2/0227 | 1.0.2 | PWJ | PowderJect Pharmaceuticals |
http://hl7.org/fhir/v2/0227 | 1.0.2 | SCL | Sclavo, Inc. |
http://hl7.org/fhir/v2/0227 | 1.0.2 | SI | Swiss Serum and Vaccine Inst. |
http://hl7.org/fhir/v2/0227 | 1.0.2 | SKB | GlaxoSmithKline |
http://hl7.org/fhir/v2/0227 | 1.0.2 | SOL | Solvay Pharmaceuticals |
http://hl7.org/fhir/v2/0227 | 1.0.2 | TAL | Talecris Biotherapeutics |
http://hl7.org/fhir/v2/0227 | 1.0.2 | UNK | Unknown manufacturer |
http://hl7.org/fhir/v2/0227 | 1.0.2 | USA | United States Army Medical Research and Material Command |
http://hl7.org/fhir/v2/0227 | 1.0.2 | VXG | VaxGen |
http://hl7.org/fhir/v2/0227 | 1.0.2 | WA | Wyeth-Ayerst |
http://hl7.org/fhir/v2/0227 | 1.0.2 | WAL | Wyeth-Ayerst |
http://hl7.org/fhir/v2/0227 | 1.0.2 | ZLB | ZLB Behring |
FHIR
FHIRsmith{
"resourceType": "ValueSet",
"id": "R2-v2-0227-for-R4B",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode": "fhir"
},
{
"extension": [
{
"url": "packageId",
"valueId": "hl7.fhir.uv.xver-r2.r4b"
},
{
"url": "version",
"valueString": "0.1.0"
},
{
"url": "uri",
"valueUri": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r4b"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/package-source"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger": 0,
"_valueInteger": {
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r4b"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode": "trial-use",
"_valueCode": {
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r2.r4b"
}
]
}
}
],
"url": "http://hl7.org/fhir/uv/xver/ValueSet/R2-v2-0227-for-R4B",
"version": "0.1.0",
"name": "R2V20227ForR4B",
"title": "Cross-version ValueSet DSTU2.v2 Manufacturers of Vaccines (code=MVX) for use in FHIR R4B",
"status": "active",
"experimental": false,
"date": "2026-03-17T21:02:03.8104715+00:00",
"publisher": "FHIR Infrastructure",
"contact": [
{
"name": "FHIR Infrastructure",
"telecom": [
{
"system": "url",
"value": "http://www.hl7.org/Special/committees/fiwg"
}
]
}
],
"description": "This cross-version ValueSet represents content from `http://hl7.org/fhir/ValueSet/v2-0227|2.8.2` for use in FHIR R4B.",
"jurisdiction": [
{
"coding": [
{
"system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code": "001",
"display": "World"
}
]
}
],
"purpose": "This value set is part of the cross-version definitions generated to enable use of the\r\nvalue set `http://hl7.org/fhir/ValueSet/v2-0227|2.8.2` as defined in FHIR DSTU2\r\nin FHIR R4B.\r\n\r\nThe source value set is bound to the following FHIR DSTU2 elements:\r\n* \r\n\r\nAcross FHIR versions, the value set has been mapped as:\r\n* `http://hl7.org/fhir/ValueSet/v2-0227|2.8.2`\n* `http://hl7.org/fhir/ValueSet/v2-0227|2.8.2`\n* `http://terminology.hl7.org/ValueSet/v2-0227|2.9`\r\n\r\nNote that all concepts are included in this cross-version definition because no concepts have compatible representations\r\n\r\nFollowing are the generation technical comments:\r\nAll concepts in the comparison are listed as identical.\nThe source and target value sets have the same number of active concepts (55).\nAll concepts in the comparison are listed as identical.\nThe source and target value sets have the same number of active concepts (55).\nFHIR ValueSet `http://hl7.org/fhir/ValueSet/v2-0227|2.8.2`, defined in FHIR DSTU2 does not have any mapping to FHIR R4B",
"compose": {
"include": [
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"concept": [
{
"code": "AB",
"display": "Abbott Laboratories"
},
{
"code": "AD",
"display": "Adams Laboratories, Inc."
},
{
"code": "ALP",
"display": "Alpha Therapeutic Corporation"
},
{
"code": "AR",
"display": "Armour"
},
{
"code": "AVB",
"display": "Aventis Behring L.L.C."
},
{
"code": "AVI",
"display": "Aviron"
},
{
"code": "BA",
"display": "Baxter Healthcare Corporation"
},
{
"code": "BAH",
"display": "Baxter Healthcare Corporation"
},
{
"code": "BAY",
"display": "Bayer Corporation"
},
{
"code": "BP",
"display": "Berna Products"
},
{
"code": "BPC",
"display": "Berna Products Corporation"
},
{
"code": "CEN",
"display": "Centeon L.L.C."
},
{
"code": "CHI",
"display": "Chiron Corporation"
},
{
"code": "CMP",
"display": "Celltech Medeva Pharmaceuticals"
},
{
"code": "CNJ",
"display": "Cangene Corporation"
},
{
"code": "CON",
"display": "Connaught"
},
{
"code": "DVC",
"display": "DynPort Vaccine Company, LLC"
},
{
"code": "EVN",
"display": "Evans Medical Limited"
},
{
"code": "GEO",
"display": "GeoVax Labs, Inc."
},
{
"code": "GRE",
"display": "Greer Laboratories, Inc."
},
{
"code": "IAG",
"display": "Immuno International AG"
},
{
"code": "IM",
"display": "Merieux"
},
{
"code": "IUS",
"display": "Immuno-U.S., Inc."
},
{
"code": "JPN",
"display": "The Research Foundation for Microbial Diseases of Osaka University"
},
{
"code": "KGC",
"display": "Korea Green Cross Corporation"
},
{
"code": "LED",
"display": "Lederle"
},
{
"code": "MA",
"display": "Massachusetts Public Health Biologic Laboratories"
},
{
"code": "MBL",
"display": "Massachusetts Biologic Laboratories"
},
{
"code": "MED",
"display": "MedImmune, Inc."
},
{
"code": "MIL",
"display": "Miles"
},
{
"code": "MIP",
"display": "Bioport Corporation"
},
{
"code": "MSD",
"display": "Merck & Co., Inc."
},
{
"code": "NAB",
"display": "NABI"
},
{
"code": "NAV",
"display": "North American Vaccine, Inc."
},
{
"code": "NOV",
"display": "Novartis Pharmaceutical Corporation"
},
{
"code": "NVX",
"display": "Novavax, Inc."
},
{
"code": "NYB",
"display": "New York Blood Center"
},
{
"code": "ORT",
"display": "Ortho-Clinical Diagnostics"
},
{
"code": "OTC",
"display": "Organon Teknika Corporation"
},
{
"code": "OTH",
"display": "Other manufacturer"
},
{
"code": "PD",
"display": "Parkedale Pharmaceuticals"
},
{
"code": "PMC",
"display": "sanofi pasteur"
},
{
"code": "PRX",
"display": "Praxis Biologics"
},
{
"code": "PWJ",
"display": "PowderJect Pharmaceuticals"
},
{
"code": "SCL",
"display": "Sclavo, Inc."
},
{
"code": "SI",
"display": "Swiss Serum and Vaccine Inst."
},
{
"code": "SKB",
"display": "GlaxoSmithKline"
},
{
"code": "SOL",
"display": "Solvay Pharmaceuticals"
},
{
"code": "TAL",
"display": "Talecris Biotherapeutics"
},
{
"code": "UNK",
"display": "Unknown manufacturer"
},
{
"code": "USA",
"display": "United States Army Medical Research and Material Command"
},
{
"code": "VXG",
"display": "VaxGen"
},
{
"code": "WA",
"display": "Wyeth-Ayerst"
},
{
"code": "WAL",
"display": "Wyeth-Ayerst"
},
{
"code": "ZLB",
"display": "ZLB Behring"
}
]
}
]
},
"expansion": {
"timestamp": "2026-03-17T21:02:03.8104715+00:00",
"contains": [
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "AB",
"display": "Abbott Laboratories"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "AD",
"display": "Adams Laboratories, Inc."
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "ALP",
"display": "Alpha Therapeutic Corporation"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "AR",
"display": "Armour"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "AVB",
"display": "Aventis Behring L.L.C."
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "AVI",
"display": "Aviron"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "BA",
"display": "Baxter Healthcare Corporation"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "BAH",
"display": "Baxter Healthcare Corporation"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "BAY",
"display": "Bayer Corporation"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "BP",
"display": "Berna Products"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "BPC",
"display": "Berna Products Corporation"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "CEN",
"display": "Centeon L.L.C."
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "CHI",
"display": "Chiron Corporation"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "CMP",
"display": "Celltech Medeva Pharmaceuticals"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "CNJ",
"display": "Cangene Corporation"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "CON",
"display": "Connaught"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "DVC",
"display": "DynPort Vaccine Company, LLC"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "EVN",
"display": "Evans Medical Limited"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "GEO",
"display": "GeoVax Labs, Inc."
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "GRE",
"display": "Greer Laboratories, Inc."
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "IAG",
"display": "Immuno International AG"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "IM",
"display": "Merieux"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "IUS",
"display": "Immuno-U.S., Inc."
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "JPN",
"display": "The Research Foundation for Microbial Diseases of Osaka University"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "KGC",
"display": "Korea Green Cross Corporation"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "LED",
"display": "Lederle"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "MA",
"display": "Massachusetts Public Health Biologic Laboratories"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "MBL",
"display": "Massachusetts Biologic Laboratories"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "MED",
"display": "MedImmune, Inc."
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "MIL",
"display": "Miles"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "MIP",
"display": "Bioport Corporation"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "MSD",
"display": "Merck & Co., Inc."
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "NAB",
"display": "NABI"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "NAV",
"display": "North American Vaccine, Inc."
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "NOV",
"display": "Novartis Pharmaceutical Corporation"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "NVX",
"display": "Novavax, Inc."
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "NYB",
"display": "New York Blood Center"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "ORT",
"display": "Ortho-Clinical Diagnostics"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "OTC",
"display": "Organon Teknika Corporation"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "OTH",
"display": "Other manufacturer"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "PD",
"display": "Parkedale Pharmaceuticals"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "PMC",
"display": "sanofi pasteur"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "PRX",
"display": "Praxis Biologics"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "PWJ",
"display": "PowderJect Pharmaceuticals"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "SCL",
"display": "Sclavo, Inc."
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "SI",
"display": "Swiss Serum and Vaccine Inst."
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "SKB",
"display": "GlaxoSmithKline"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "SOL",
"display": "Solvay Pharmaceuticals"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "TAL",
"display": "Talecris Biotherapeutics"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "UNK",
"display": "Unknown manufacturer"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "USA",
"display": "United States Army Medical Research and Material Command"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "VXG",
"display": "VaxGen"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "WA",
"display": "Wyeth-Ayerst"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "WAL",
"display": "Wyeth-Ayerst"
},
{
"system": "http://hl7.org/fhir/v2/0227",
"version": "1.0.2",
"code": "ZLB",
"display": "ZLB Behring"
}
]
}
}